[Form 4] UNITED STATES ANTIMONY CORP Insider Trading Activity

Rhea-AI Filing Summary

United States Antimony Corp (UAMY) insider filing: Richard R. Isaak, SVP and Chief Financial Officer, reported awards on May 27, 2025 that were filed on Form 4. He received a time-based restricted stock unit award covering 180,000 common shares that vests one-third each on May 27 of 2025, 2026 and 2027, subject to continued service and shareholder approval of the company’s Amended Restated 2023 Equity Incentive Plan. He also received a stock option covering 200,000 underlying shares with an exercise price of $2.57, vesting upon satisfaction of specified performance measures during the option’s 10-year term and also conditioned on shareholder approval.

Positive

• Significant retention incentives: Grants of 180,000 RSU-equivalent shares and 200,000 option-underlying shares align the CFO with long-term shareholder value creation
• Performance and service alignment: RSUs vest over three years and the option vests on performance measures, tying compensation to results

Negative

• Contingent on shareholder approval: Both awards require approval of the Amended Restated 2023 Equity Incentive Plan, so awards are not guaranteed
• Potential dilution: If approved and fully vested/exercised, the awards could dilute existing shareholders depending on total share count

Insights

Financial Analyst

TL;DR: Insider awards align executive incentives but are contingent on shareholder approval, so near-term ownership unchanged.

The filing documents sizeable equity awards to the CFO totaling 380,000 underlying shares (180,000 RSU equivalents and 200,000 stock option underlying shares). These grants are structured to retain and motivate management via time-based vesting and performance gates. Because both awards are explicitly contingent on shareholder approval of the Amended Restated 2023 Equity Incentive Plan, they do not immediately increase reported beneficial ownership. The stock option exercise price of $2.57 and the 10-year term are permissive but vesting tied to performance limits near-term dilutive impact.

Corporate Governance Expert

TL;DR: Governance-wise, conditional grants are standard but place importance on upcoming shareholder vote.

The disclosure is transparent about contingencies and vesting schedules. Time-based RSUs vest in three equal tranches with continued service requirements; the option vests on achieving performance measures at any time within a 10-year window. Materiality to shareholders depends on whether the company secures approval for the Amended Restated 2023 Equity Incentive Plan; absent approval, the awards will not become effective. This makes the shareholder meeting outcome the key governance event related to these awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ISAAK RICHARD R

(Last) (First) (Middle)

4438 W LOVERS LANE

UNIT 100

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(1)	$0	05/27/2025		A		180,000(1)		(1)	(1)	Common Stock	180,000	(1)	0(1)	D
Stock Option(2)	$2.57	05/27/2025		A		200,000(2)		(2)	(2)	Common Stock	200,000	(2)	0(2)	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The RSU will vest as to one-third, or 60,000 shares of the 180,000 total number of shares on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

2. Represents shares of Common Stock underlying a stock option award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

	/s/ Richard R. Isaak	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did UAMY CFO Richard Isaak report on Form 4?

He reported grants on May 27, 2025 of 180,000 RSU-equivalent shares and a stock option covering 200,000 underlying shares with an exercise price of $2.57.

Are the reported awards immediately effective for UAMY?

No. Both awards are explicitly contingent on shareholder approval of the Amended Restated 2023 Equity Incentive Plan.

When do the RSUs vest for the 180,000 shares?

The RSUs vest in three equal tranches of 60,000 shares on May 27 of 2025, 2026 and 2027, subject to continued service and shareholder approval.

What are the key terms of the stock option reported for UAMY?

The stock option covers 200,000 underlying shares with an exercise price of $2.57, a 10-year term, and vests upon meeting specified performance measures.

Does this Form 4 change Richard Isaak’s current ownership?

Not until the contingency is resolved; the filing shows awards granted but conditioned on shareholder approval, so reported beneficial ownership does not increase immediately.